ArticleBMC health services research2025
Practices and attitudes of adult psychiatrists regarding methamphetamine-associated psychotic disorder: an internet based survey conducted in Turkey.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.Journal of medical Internet research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany variables may affect approaches of psychiatrists to methamphetamine-associated psychotic disorder (MAP) treatment. This study was aimed to reach adult psychiatrists actively practicing in Turkey through an internet-based survey and to determine their practices and attitudes to MAP treatment.
methodsIn this internet-based study, participants were divided into three groups based on their answers: Those who do not follow-up any MAP patient were group 1 (n = 78), partially involved in the treatment process of at least one patient diagnosed with MAP were group 2 (n = 128), completely involved in the treatment process of at least one patient diagnosed with MAP were group 3 (n = 202).
resultsPsychotropic preferences in insomnia (p < 0.001), typical oral antipsychotic choice (p < 0.001), preferred doses of olanzapine/risperidone/aripiprazole/amisulpride for maintenance treatment (p < 0.001), long-acting injectable antipsychotic use practices (p < 0.001), non-antipsychotic psychotropic use characteristics (p < 0.001), extrapyramidal system side effect experiences (p < 0.001), delirium and life-threatening situations encounter rates (p < 0.001) were significantly different between group 2 and group 3. While the duration of maintenance with antipsychotics in the first MAP episode was similar between group 2 and group 3 (p = 0.254), it was different in the second and subsequent MAP episodes (p < 0.05). A binary logistic regression model containing the experiences of long-acting injectable antipsychotic use, extrapyramidal system side effect, and delirium was created (overall p < 0.001, Nagelkerke R
conclusionsThis first study in the field, which examines the current issue in detail, reveals that there are many factors that seriously affect psychiatrists' approaches to MAP treatment in Turkey.
trial registrationThis study was approved by the Ethics Committee of the Fırat University (Date: 14/09/2023; Number: 2023/12-12).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.